Epidemiology of fragility fractures in Italy.

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMC 3279081)

Published in Clin Cases Miner Bone Metab on May 01, 2011

Authors

Prisco Piscitelli1, Maria Luisa Brandi, Giovanna Chitano, Alberto Argentiero, Cosimo Neglia, Alessandro Distante, Luca Saturnino, Umberto Tarantino

Author Affiliations

1: University of Florence, Florence, Italy.

Articles citing this

Updated incidence rates of fragility fractures in Italy: extension study 2002-2008. Clin Cases Miner Bone Metab (2011) 1.08

Clinical and surgical approach of severe bone fragility fracture: clinical case of 4 fragility fracture in patient with heavy osteoporosis. Clin Cases Miner Bone Metab (2013) 0.97

Current medical treatment strategies concerning fracture healing. Clin Cases Miner Bone Metab (2013) 0.95

Antifracture drugs consumption in Tuscany Region before the Target Project: a valuable model for the analysis of administrative database. Clin Cases Miner Bone Metab (2012) 0.85

Evaluation of fracture risk and fracture prevention: an Italian picture. Clin Cases Miner Bone Metab (2012) 0.78

Descriptive epidemiology of traumatic injuries in 18890 adults: a 5-year-study in a tertiary trauma center in iran. Asian J Sports Med (2015) 0.77

In Hospital and 3-Month Mortality and Functional Recovery Rate in Patients Treated for Hip Fracture by a Multidisciplinary Team. PLoS One (2016) 0.75

Bone care nurses and the evolution of the nurse's educational function: the Guardian Angel(®) research project. Clin Cases Miner Bone Metab (2015) 0.75

The role of the orthopaedic surgeon in the prevention of refracture in patients treated surgically for fragility hip and vertebral fracture. Clin Cases Miner Bone Metab (2014) 0.75

Predictive Factors for Pressure Ulcers in an Older Adult Population Hospitalized for Hip Fractures: A Prognostic Cohort Study. PLoS One (2017) 0.75

Articles cited by this

Epidemiology and outcomes of osteoporotic fractures. Lancet (2002) 13.09

FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int (2008) 8.75

Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res (2000) 7.29

Risk of new vertebral fracture in the year following a fracture. JAMA (2001) 6.17

The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone (1995) 5.76

European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2008) 5.27

The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res (1996) 3.25

The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med (1998) 3.13

Contribution of vertebral deformities to chronic back pain and disability. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res (1992) 2.82

The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int (2006) 2.24

The effect of age, weight, and lifestyle factors on calcaneal quantitative ultrasound: the ESOPO study. Osteoporos Int (2003) 2.22

Quantitative heel ultrasound in a population-based study in Italy and its relationship with fracture history: the ESOPO study. Osteoporos Int (2005) 1.80

Prediction of hip fracture risk by quantitative ultrasound in more than 7000 Swiss women > or =70 years of age: comparison of three technologically different bone ultrasound devices in the SEMOF study. J Bone Miner Res (2006) 1.78

Mortality associated with vertebral deformity in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (1998) 1.76

Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study. Osteoporos Int (2003) 1.74

Incidence and costs of hip fractures compared to acute myocardial infarction in the Italian population: a 4-year survey. Osteoporos Int (2006) 1.54

Asymptomatic vertebral deformity as a major risk factor for subsequent fractures and mortality: a long-term prospective study. J Bone Miner Res (2005) 1.51

Hip fractures in Italy: 2000-2005 extension study. Osteoporos Int (2009) 1.36

Proximal humeral fracture as a risk factor for subsequent hip fractures. J Bone Joint Surg Am (2009) 1.28

The incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures in Italy: results from a 3-year multicenter study. Arthritis Res Ther (2010) 1.17

Reporting of vertebral fractures on spine X-rays. Osteoporos Int (2005) 1.06

Hip fracture in Italy: analysis of DRG data. Aging Clin Exp Res (2007) 0.92

Articles by these authors

Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med (2002) 5.83

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48

Partial thrombosis of the false lumen in patients with acute type B aortic dissection. N Engl J Med (2007) 3.92

Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab (2012) 2.87

The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann Intern Med (2006) 2.74

Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res (2015) 2.74

Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. J Bone Miner Res (2008) 2.66

Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA (2008) 2.52

Diagnosis of acute aortic dissection by D-dimer: the International Registry of Acute Aortic Dissection Substudy on Biomarkers (IRAD-Bio) experience. Circulation (2009) 2.45

Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab (2014) 2.38

Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension. J Bone Miner Res (2012) 2.34

Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res (2011) 2.30

Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA (2004) 2.20

Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab (2014) 1.98

Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS study. PLoS Med (2006) 1.68

Estrogen receptor expression in cutaneous melanoma: a real-time reverse transcriptase-polymerase chain reaction and immunohistochemical study. Arch Dermatol (2009) 1.67

Assessment of gene-by-sex interaction effect on bone mineral density. J Bone Miner Res (2012) 1.58

Osteoprotegerin serum levels in Kawasaki disease: an additional potential marker in predicting children with coronary artery involvement. J Rheumatol (2005) 1.46

The occurrence of acute myocardial infarction in Italy: a five-year analysis of hospital discharge records. Aging Clin Exp Res (2010) 1.44

Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler Thromb Vasc Biol (2003) 1.39

The role of estrogens in melanoma and skin cancer. Carcinogenesis (2009) 1.38

Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis. J Bone Miner Res (2002) 1.29

A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. J Clin Endocrinol Metab (2004) 1.25

Multiple endocrine neoplasia type 2. Orphanet J Rare Dis (2006) 1.23

Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J Am Soc Nephrol (2002) 1.21

Genome-wide association identifies three new susceptibility loci for Paget's disease of bone. Nat Genet (2011) 1.20

Calcium sensing receptor signalling in physiology and cancer. Biochim Biophys Acta (2012) 1.19

The incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures in Italy: results from a 3-year multicenter study. Arthritis Res Ther (2010) 1.17

Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis. J Immunol (2004) 1.17

Indications and limitations for a neonatal pulse oximetry screening of critical congenital heart disease. J Perinat Med (2005) 1.11

Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1? Ann Surg (2007) 1.10

Treatment of desmoids and mesenteric fibromatosis in familial adenomatous polyposis with raloxifene. Tumori (2003) 1.08

Multiple endocrine neoplasia type 1. Orphanet J Rare Dis (2006) 1.08

Updated incidence rates of fragility fractures in Italy: extension study 2002-2008. Clin Cases Miner Bone Metab (2011) 1.08

Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study. Bone (2007) 1.07

Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. Eur J Endocrinol (2010) 1.04

Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors. Genet Med (2009) 1.03

Somatostatinoma: clinico-pathological features of three cases and literature reviewed. J Gastroenterol Hepatol (2007) 1.02

Genetic determinants of heel bone properties: genome-wide association meta-analysis and replication in the GEFOS/GENOMOS consortium. Hum Mol Genet (2014) 1.02

Incidence of breast cancer in Italy: mastectomies and quadrantectomies performed between 2000 and 2005. J Exp Clin Cancer Res (2009) 1.02

Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability. Cardiovasc Res (2009) 1.01

Total knee arthroplasty in patients with hypersensitivity to metals. Int Orthop (2014) 1.00

Homocysteine induces VCAM-1 gene expression through NF-kappaB and NAD(P)H oxidase activation: protective role of Mediterranean diet polyphenolic antioxidants. Am J Physiol Heart Circ Physiol (2007) 1.00

Muscle-bone interactions: basic and clinical aspects. Endocrine (2013) 1.00

Determinants of bone turnover markers in healthy premenopausal women. Calcif Tissue Int (2008) 0.99

ERbeta is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components. Endocr Relat Cancer (2005) 0.97

Cystic bone angiomatosis: a case report treated with aminobisphosphonates and review of the literature. Calcif Tissue Int (2013) 0.97

A review on strontium ranelate long-term antifracture efficacy in the treatment of postmenopausal osteoporosis. Ther Adv Musculoskelet Dis (2013) 0.97

Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias. Ann Surg (2006) 0.96

Preliminary experience with the smooth muscle troponin-like protein, calponin, as a novel biomarker for diagnosing acute aortic dissection. Eur Heart J (2008) 0.95

Biomarker-assisted diagnosis of acute aortic dissection: how far we have come and what to expect. Curr Opin Cardiol (2010) 0.94

Myostatin polymorphisms and age-related sarcopenia in the Italian population. J Am Geriatr Soc (2002) 0.93

The TARGET project in Tuscany: the first disease management model of a regional project for the prevention of hip re-fractures in the elderly. Clin Cases Miner Bone Metab (2010) 0.93

Polyostotic form of fibrous dysplasia in a 13 years old Colombian girl showing clinical and biochemical response to neridronate intravenous therapy. Clin Cases Miner Bone Metab (2009) 0.92

In vitro blockade of receptor activator of nuclear factor-kappaB ligand prevents osteoclastogenesis induced by neuroblastoma cells. Int J Cancer (2004) 0.91

Bone vascularization in normal and disease conditions. Front Endocrinol (Lausanne) (2013) 0.91

MicroRNA Role in Thyroid Cancer Development. J Thyroid Res (2011) 0.91

Multinational survey of osteoporotic fracture management. Osteoporos Int (2004) 0.91

Targeted approaches in the treatment of osteoporosis: differential mechanism of action of denosumab and clinical utility. Ther Clin Risk Manag (2012) 0.90

Selective oestrogen receptor modulators in desmoid tumours. Expert Opin Investig Drugs (2004) 0.90

Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease. J Bone Miner Res (2013) 0.89

Relationship of estrogen receptor genotypes to bone mineral density and to rates of bone loss in men. J Clin Endocrinol Metab (2004) 0.89

The negative feedback-loop between the oncomir Mir-24-1 and menin modulates the Men1 tumorigenesis by mimicking the "Knudson's second hit". PLoS One (2012) 0.89

Estrogen receptor alpha and beta polymorphisms: is there an association with bone mineral density, plasma lipids, and response to postmenopausal hormone therapy? Menopause (2006) 0.88

Multiple endocrine neoplasms. Best Pract Res Clin Rheumatol (2008) 0.88

PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium. Cardiovasc Res (2009) 0.88

Reduced serum homocysteine levels in type 2 diabetes. Nutr Metab Cardiovasc Dis (2005) 0.88

In vitro differentiation of human mesenchymal stem cells on Ti6Al4V surfaces. Biomaterials (2007) 0.88

The burden of breast cancer in Italy: mastectomies and quadrantectomies performed between 2001 and 2008 based on nationwide hospital discharge records. J Exp Clin Cancer Res (2012) 0.88

A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet. Nat Clin Pract Endocrinol Metab (2008) 0.88

Methodological models for in vitro amplification and maintenance of human articular chondrocytes from elderly patients. Biogerontology (2007) 0.88

Inhibition of angiogenesis via FGF-2 blockage in primitive and bone metastatic renal cell carcinoma. Anticancer Res (2007) 0.87

Transglutaminases expression in human supraspinatus tendon ruptures and in mouse tendons. Biochem Biophys Res Commun (2009) 0.87

Thyroid cancer: current molecular perspectives. J Oncol (2010) 0.87

Segregation of a M404V mutation of the p62/sequestosome 1 (p62/SQSTM1) gene with polyostotic Paget's disease of bone in an Italian family. Arthritis Res Ther (2005) 0.87

Strontium Ranelate and bone healing: report of two cases. Clin Cases Miner Bone Metab (2010) 0.87

Pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: review of literature. Endocr Pract (2011) 0.86

Experimental investigations of nonlinearities and destruction mechanisms of an experimental phospholipid-based ultrasound contrast agent. Invest Radiol (2007) 0.86

Evaluation of persistence and adherence to teriparatide treatment in patients affected by severe osteoporosis (PATT): a multicenter observational real life study. Clin Cases Miner Bone Metab (2013) 0.86

Can fibroblast growth factor (FGF)-23 circulating levels suggest coronary artery abnormalities in children with Kawasaki disease? Clin Exp Rheumatol (2013) 0.86

Incidence and costs of hip fractures vs strokes and acute myocardial infarction in Italy: comparative analysis based on national hospitalization records. Clin Interv Aging (2012) 0.86